Viking Therapeutics Inc (VKTX)
67.50
-1.56
(-2.26%)
USD |
NASDAQ |
May 20, 16:00
67.74
+0.24
(+0.36%)
After-Hours: 20:00
Viking Therapeutics Market Cap: 7.443B for May 20, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| May 17, 2024 | 7.388B |
| May 16, 2024 | 7.615B |
| May 15, 2024 | 8.602B |
| May 14, 2024 | 7.994B |
| May 13, 2024 | 7.978B |
| May 10, 2024 | 8.120B |
| May 09, 2024 | 8.844B |
| May 08, 2024 | 8.812B |
| May 07, 2024 | 8.778B |
| May 06, 2024 | 8.624B |
| May 03, 2024 | 8.487B |
| May 02, 2024 | 8.354B |
| May 01, 2024 | 8.428B |
| April 30, 2024 | 8.775B |
| April 29, 2024 | 8.316B |
| April 26, 2024 | 8.194B |
| April 25, 2024 | 7.593B |
| April 24, 2024 | 7.175B |
| April 23, 2024 | 7.160B |
| April 22, 2024 | 7.041B |
| April 19, 2024 | 6.993B |
| April 18, 2024 | 7.131B |
| April 17, 2024 | 7.330B |
| April 16, 2024 | 7.493B |
| April 15, 2024 | 7.382B |
| Date | Value |
|---|---|
| April 12, 2024 | 7.564B |
| April 11, 2024 | 7.812B |
| April 10, 2024 | 7.898B |
| April 09, 2024 | 8.028B |
| April 08, 2024 | 8.364B |
| April 05, 2024 | 8.427B |
| April 04, 2024 | 8.122B |
| April 03, 2024 | 8.646B |
| April 02, 2024 | 8.526B |
| April 01, 2024 | 8.763B |
| March 28, 2024 | 9.038B |
| March 27, 2024 | 9.173B |
| March 26, 2024 | 8.897B |
| March 25, 2024 | 7.616B |
| March 22, 2024 | 7.655B |
| March 21, 2024 | 7.770B |
| March 20, 2024 | 7.819B |
| March 19, 2024 | 7.174B |
| March 18, 2024 | 6.973B |
| March 15, 2024 | 6.886B |
| March 14, 2024 | 7.114B |
| March 13, 2024 | 7.869B |
| March 12, 2024 | 7.338B |
| March 11, 2024 | 6.938B |
| March 08, 2024 | 7.850B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
163.26M
Minimum
Jun 16 2022
9.989B
Maximum
Mar 04 2024
1.045B
Average
497.29M
Median
Sep 14 2021
Market Cap Benchmarks
| Amgen Inc | 168.74B |
| Eli Lilly and Co | 744.65B |
| Pfizer Inc | 161.70B |
| Madrigal Pharmaceuticals Inc | 4.948B |
| Terns Pharmaceuticals Inc | 404.56M |
Market Cap Related Metrics
| Price to Book Value | 7.970 |
| Price | 67.50 |
| Earnings Yield | -1.38% |